MedTrace Logo

Oxycodone or Standard Pain Therapy in Treating Patients With Cancer Pain

NCT00378937 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2013-08-02

No results posted yet for this study

Summary

RATIONALE: Oxycodone helps lessen pain caused by cancer and may improve quality of life. It is not yet known whether oxycodone works better and is more cost effective than standard therapy in treating patients with cancer pain.

PURPOSE: This randomized phase IV trial is studying oxycodone to see how well it works compared with standard pain therapy in treating patients with cancer pain and if it is more cost effective than standard pain therapy.

Conditions

  • Pain
  • Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG

acetaminophen

DRUG

codeine phosphate

DRUG

dextropropoxyphene hydrochloride

DRUG

morphine sulfate

DRUG

oxycodone hydrochloride

PROCEDURE

management of therapy complications

PROCEDURE

quality-of-life assessment

Sponsors & Collaborators

  • University Hospitals Bristol and Weston NHS Foundation Trust

    lead OTHER

Principal Investigators

  • Geoff Hanks, MD · University Hospitals Bristol and Weston NHS Foundation Trust

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-01-31
Completion
2006-02-28

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00378937 on ClinicalTrials.gov